Dose Modifications and Treatment Sequencing

This segment explores the role of dose adjustments and treatment sequencing in managing toxicity without compromising efficacy. Panelists review clinical evidence showing that temporary dose modifications can reduce side adverse effects while maintaining comparable progression-free survival outcomes. They share practical approaches for implementing dose interruptions or reductions in response to specific toxicities and discuss how these decisions affect both first-line and future treatment options. The conversation also covers strategies to balance immediate symptom management with long-term disease control through individualized treatment plans.